What amount sold does VIP Fund II, LLC report in Form D filings?

The latest linked filings report $20M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was VIP Fund II, LLC's most recent SEC filing?

VIP Fund II, LLC's most recent Form D filing was on 2023-10-10.

How many investors does VIP Fund II, LLC have?

The most recent Form D filing lists 78 investor(s).

What type of securities does VIP Fund II, LLC offer?

VIP Fund II, LLC's SEC Form D filings indicate equity offerings.

VIP Fund II, LLC

CIK: 0001996793·Other·ROSEVILLE, CA·Limited Liability Company·Founded 2019

Reported Sold

$20,000,000

Total Filings

Identified Offerings

Last Filed

Oct 10, 2023

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other industry

SEC EDGAR

Offering filing timeline

Oct 10, 2023Form D — New notice

Reported sold: $20,000,000 · Target: $20,000,000

Rule 506(b)·78 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$20,000,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Jason Johnson

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 10, 2023	New	$20,000,000	$20,000,000	78

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Agilis Medical, Inc.

Other

Offering target: $10,000,000

Filed Oct 28, 2026